2 unchanged sentences
Our common stock is traded on The Nasdaq Global Market under the symbol “AGLE.”
−Removed: As of March 12, 2021, there were approximately 21 stockholders of record of our common stock based on information provided by our transfer agent.
+Added: As of February 24, 2022, there were approximately 20 stockholders of record of our common stock based on information provided by our transfer agent.
The actual number of stockholders is greater than this number of record holders, and includes stockholders who are beneficial owners, but whose shares are held in street name by brokers and other nominees.
2 unchanged sentences
This graph shall not be deemed “soliciting material” or be deemed “filed” for purposes of Section 18 of the Exchange Act, or otherwise subject to the liabilities under that Section, and shall not be deemed to be incorporated by reference into any of our filings under the Securities Act whether made before or after the date hereof and irrespective of any general incorporation language in any such filing.
−Removed: The following stock performance graph compares our total stock return with the total return for (i) the Nasdaq Composite Index and the (ii) the Nasdaq Biotechnology Index for the period from April 7, 2016 (the date our common stock commenced trading on the Nasdaq Global Market) through December 31, 2020.
−Removed: The figures represented below assume an investment of $100 in our common stock at the closing price of $9.77 on April 7, 2016 and in the Nasdaq Composite Index and the Nasdaq Biotechnology Index on April 7, 2016 and the reinvestment of dividends into shares of common stock.
+Added: The following stock performance graph compares our total stock return with the total return for (i) the Nasdaq Composite Index and the (ii) the Nasdaq Biotechnology Index for the period from December 31, 2016 through December 31, 2021.
+Added: The figures represented below assume an investment of $100 in our common stock at the closing price of $4.35 on December 31, 2016 and in the Nasdaq Composite Index and the Nasdaq Biotechnology Index on December 31, 2016 and the reinvestment of dividends into shares of common stock.
The comparisons in the table are required by the SEC and are not intended to forecast or be indicative of possible future performance of our common stock.
10 unchanged sentences
Purchases of Equity Securities by the Issuer and Affiliated Purchasers
−Removed: SELECTED CONSOLIDATED FINANCIAL DATA
−Removed: We are a smaller reporting company and emerging growth company, as defined by Rule 12b-2 of the Exchange Act, and are not required to provide this information.
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.